• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆核苷逆转录酶抑制剂浓度与 HIV 感染者认知功能的相关性。

Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.

机构信息

Institute for Global Health, University College London, London, United Kingdom.

Department of Infectious Disease, Imperial College London, London, United Kingdom.

出版信息

PLoS One. 2021 Jul 21;16(7):e0253861. doi: 10.1371/journal.pone.0253861. eCollection 2021.

DOI:10.1371/journal.pone.0253861
PMID:34288920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8294567/
Abstract

OBJECTIVES

To investigate the associations of plasma lamivudine (3TC), abacavir (ABC), emtricitabine (FTC) and tenofovir (TFV) concentrations with cognitive function in a cohort of treated people with HIV (PWH).

METHODS

Pharmacokinetics (PK) and cognitive function (Cogstate, six domains) data were obtained from PWH recruited in the POPPY study on either 3TC/ABC or FTC/tenofovir disoproxil fumarate (TDF)-containing regimens. Association between PK parameters (AUC0-24: area under the concentration-time curve over 24 hours, Cmax: maximum concentration and Ctrough: trough concentration) and cognitive scores (standardized into z-scores) were evaluated using rank regression adjusting for potential confounders.

RESULTS

Median (IQR) global cognitive z-scores in the 83 PWH on 3TC/ABC and 471 PWH on FTC/TDF were 0.14 (-0.27, 0.38) and 0.09 (-0.28, 0.42), respectively. Higher 3TC AUC0-24 and Ctrough were associated with better global z-scores [rho = 0.29 (p = 0.02) and 0.27 (p = 0.04), respectively], whereas higher 3TC Cmax was associated with poorer z-scores [rho = -0.31 (p<0.01)], independently of ABC concentrations. Associations of ABC PK parameters with global and domain z-scores were non-significant after adjustment for confounders and 3TC concentrations (all p's>0.05). None of the FTC and TFV PK parameters were associated with global or domain cognitive scores.

CONCLUSIONS

Whilst we found no evidence of either detrimental or beneficial effects of ABC, FTC and TFV plasma exposure on cognitive function of PWH, higher plasma 3TC exposures were generally associated with better cognitive performance although higher peak concentrations were associated with poorer performance.

摘要

目的

研究血浆拉米夫定(3TC)、阿巴卡韦(ABC)、恩曲他滨(FTC)和替诺福韦(TFV)浓度与接受抗 HIV 治疗人群(PWH)认知功能的相关性。

方法

从参加 POPPY 研究的接受 3TC/ABC 或 FTC/替诺福韦二吡呋酯(TDF)方案治疗的 PWH 中获得药代动力学(PK)和认知功能(Cogstate,六个领域)数据。使用秩回归调整潜在混杂因素,评估 PK 参数(AUC0-24:24 小时内浓度-时间曲线下面积、Cmax:最大浓度和 Ctrough:谷浓度)与认知评分(标准化为 z 分数)之间的相关性。

结果

在 83 名接受 3TC/ABC 和 471 名接受 FTC/TDF 的 PWH 中,全球认知 z 评分中位数(IQR)分别为 0.14(-0.27,0.38)和 0.09(-0.28,0.42)。较高的 3TC AUC0-24 和 Ctrough 与更好的全球 z 评分相关[rho=0.29(p=0.02)和 0.27(p=0.04)],而较高的 3TC Cmax 与较差的 z 评分相关[rho=-0.31(p<0.01)],独立于 ABC 浓度。在调整混杂因素和 3TC 浓度后,ABC PK 参数与全球和领域 z 评分的相关性均无统计学意义(所有 p 值均>0.05)。FTC 和 TFV PK 参数均与全球或领域认知评分无关。

结论

虽然我们没有发现 ABC、FTC 和 TFV 血浆暴露对 PWH 认知功能的有害或有益影响,但较高的血浆 3TC 暴露通常与更好的认知表现相关,尽管较高的峰值浓度与较差的表现相关。

相似文献

1
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.血浆核苷逆转录酶抑制剂浓度与 HIV 感染者认知功能的相关性。
PLoS One. 2021 Jul 21;16(7):e0253861. doi: 10.1371/journal.pone.0253861. eCollection 2021.
2
SWIFT: prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen.SWIFT:一项前瞻性 48 周研究,旨在评估在接受含蛋白酶抑制剂的增效型抗逆转录病毒方案治疗且病毒学抑制的 HIV-1 感染者中,由拉米夫定/阿巴卡韦转换为恩曲他滨/替诺福韦的疗效和安全性。
Clin Infect Dis. 2013 Jun;56(11):1637-45. doi: 10.1093/cid/cis1203. Epub 2013 Jan 29.
3
Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018.自2018年以来,接受过治疗的HIV感染者更换或重新开始抗逆转录病毒治疗方案的医疗资源利用情况及治疗费用。
J Manag Care Spec Pharm. 2024 Aug;30(8):817-824. doi: 10.18553/jmcp.2024.30.8.817.
4
Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.核苷类逆转录酶抑制剂骨架对基于蛋白酶抑制剂的一线强化高效抗逆转录病毒治疗疗效的影响:5168 例患者 12 项临床试验的荟萃回归分析。
HIV Med. 2009 Oct;10(9):527-35. doi: 10.1111/j.1468-1293.2009.00724.x.
5
Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial.基于艾滋病临床试验组5202临床试验,对替诺福韦/恩曲他滨及阿巴卡韦/拉米夫定联合依法韦仑或阿扎那韦/利托那韦用于英国初治HIV-1感染成人患者进行成本效益分析。
HIV Med. 2016 Aug;17(7):505-15. doi: 10.1111/hiv.12349. Epub 2015 Dec 9.
6
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.在接受阿巴卡韦-拉米夫定或替诺福韦酯-恩曲他滨与阿扎那韦-利托那韦或依非韦伦治疗的受试者中,脂肪线粒体 DNA 及其功能的变化:艾滋病临床试验组研究 A5224s,A5202 的子研究。
J Infect Dis. 2013 Feb 15;207(4):604-11. doi: 10.1093/infdis/jis720. Epub 2012 Nov 29.
7
Brief Report: Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women With HIV: Laboratory and Clinical Outcomes in an Observational National Study.简要报告:在接受抗 HIV 治疗的孕妇中使用阿巴卡韦/拉米夫定和替诺福韦/恩曲他滨:一项观察性全国研究中的实验室和临床结局。
J Acquir Immune Defic Syndr. 2018 May 1;78(1):99-104. doi: 10.1097/QAI.0000000000001640.
8
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.在接受依非韦伦或阿扎那韦-利托那韦联合治疗的抗逆转录病毒初治患者中,随机分配接受阿巴卡韦-拉米夫定或替诺福韦酯-富马酸二吡呋酯-恩曲他滨:艾滋病临床治疗试验组 A5224s,A5202 的子研究。
J Infect Dis. 2011 Jun 15;203(12):1791-801. doi: 10.1093/infdis/jir188.
9
Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain.度鲁特韦/阿巴卡韦/拉米夫定固定剂量复方制剂作为西班牙HIV阳性患者初始治疗的成本效用分析
Farm Hosp. 2017 Sep 1;41(5):601-610. doi: 10.7399/fh.10808.
10
Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profiles.在胆固醇升高的HIV感染成人中,从阿巴卡韦/拉米夫定转换为替诺福韦/恩曲他滨:对血脂谱的影响。
Antivir Ther. 2012;17(6):1011-20. doi: 10.3851/IMP2305. Epub 2012 Aug 15.

引用本文的文献

1
Single-Cell Transcriptome Patterns of Transposable Elements in Alzheimer's Disease.阿尔茨海默病中转座元件的单细胞转录组模式
Mol Neurobiol. 2025 Jun 19. doi: 10.1007/s12035-025-05140-9.
2
The reverse transcriptase inhibitor 3TC modulates hippocampal transcriptome signatures of inflammation in tauopathy model mice.逆转录酶抑制剂 3TC 调节tau 病模型小鼠海马转录组炎症特征。
Exp Gerontol. 2024 Jul;192:112458. doi: 10.1016/j.exger.2024.112458. Epub 2024 May 21.
3
Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays.

本文引用的文献

1
Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIV.HIV 感染者血浆核苷酸逆转录酶抑制剂浓度及其与肝肾功能参数的关系。
AIDS. 2020 Apr 1;34(5):790-793. doi: 10.1097/QAD.0000000000002479.
2
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.利托那韦增强型达芦那韦在 HIV 感染成年人中与拉替拉韦或替诺福韦二吡呋酯/恩曲他滨联合应用的群体药代动力学和药物遗传学及其与病毒学应答的关系:NEAT001/ANRS143 随机试验的亚研究。
J Antimicrob Chemother. 2020 Mar 1;75(3):628-639. doi: 10.1093/jac/dkz479.
3
使用血清学和分子诊断检测相结合的方法对就诊于英国国家临床服务机构的罕见自发性人类免疫缺陷病毒病毒控制者进行特征分析。
Open Forum Infect Dis. 2023 Mar 1;10(5):ofad108. doi: 10.1093/ofid/ofad108. eCollection 2023 May.
Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid.转换为基于替诺福韦艾拉酚胺的治疗方案:脑脊液中的药代动力学和抗病毒活性。
Clin Infect Dis. 2020 Aug 14;71(4):982-988. doi: 10.1093/cid/ciz926.
4
Cerebral Vascular Toxicity of Antiretroviral Therapy.抗逆转录病毒治疗的脑血管毒性。
J Neuroimmune Pharmacol. 2021 Mar;16(1):74-89. doi: 10.1007/s11481-019-09858-x. Epub 2019 Jun 17.
5
Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.HIV 感染者和可比 HIV 阴性对照者中的抑郁、生活方式因素与认知功能。
HIV Med. 2019 Apr;20(4):274-285. doi: 10.1111/hiv.12714. Epub 2019 Feb 8.
6
Cognitive Impairment in people living with HIV in the ART era: A Review.抗逆转录病毒治疗时代艾滋病毒感染者的认知障碍:综述。
Br Med Bull. 2018 Sep 1;127(1):55-68. doi: 10.1093/bmb/ldy019.
7
Cohort profile: The Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study.队列简介:50岁以上人群的药代动力学与临床观察(POPPY)研究
Int J Epidemiol. 2018 Oct 1;47(5):1391-1392e. doi: 10.1093/ije/dyy072.
8
Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.中枢神经系统药物的临床药代动力学和药效动力学。
Clin Pharmacokinet. 2018 Sep;57(9):1059-1074. doi: 10.1007/s40262-018-0632-y.
9
Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.核苷类逆转录酶抑制剂降低治疗 HIV 的策略:评估证据。
HIV Med. 2018 Jan;19(1):18-32. doi: 10.1111/hiv.12534. Epub 2017 Jul 24.
10
A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV Detection.一种采用超高效液相色谱结合紫外检测法定量测定多替拉韦的验证方法。
Ther Drug Monit. 2016 Jun;38(3):327-31. doi: 10.1097/FTD.0000000000000286.